(Q35763693)

10 August 2017

1 reference

title

Intracellular signaling pathways for norepinephrine- and endothelin-1-mediated regulation of myocardial cell apoptosis (English)

1 reference

10 August 2017

0 references

Eri Iwai-Kanai

1

1 reference

10 August 2017

Koji Hasegawa

series ordinal

2

1 reference

10 August 2017

language of work or name

1 reference

1 April 2004

1 reference

Molecular and Cellular Biochemistry

10 August 2017

published in

1 reference

10 August 2017

volume

259

1 reference

10 August 2017

issue

1-2

1 reference

10 August 2017

page(s)

163-168

1 reference

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure

10 August 2017

cites work

1 reference

12 December 2020

beta-Adrenergic pathway induces apoptosis through calcineurin activation in cardiac myocytes

1 reference

12 December 2020

Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response

1 reference

12 December 2020

Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure

1 reference

12 December 2020

The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain.

1 reference

12 December 2020

MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type

1 reference

12 December 2020

Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol

1 reference

12 December 2020

RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1

1 reference

12 December 2020

Apoptosis in pressure overload-induced heart hypertrophy in the rat.

1 reference

12 December 2020

Inhibition of myocardial endothelin pathway improves long-term survival in heart failure

1 reference

12 December 2020

Agonist regulation of gene expression of adrenergic receptors and G proteins

1 reference

12 December 2020

Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion

1 reference

12 December 2020

Apoptosis by death factor

1 reference

12 December 2020

The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice

1 reference

12 December 2020

Basic fibroblast growth factor protects cardiac myocytes from iNOS-mediated apoptosis

1 reference

12 December 2020

Dual actions of the Galpha(q) agonist Pasteurella multocida toxin to promote cardiomyocyte hypertrophy and enhance apoptosis susceptibility

1 reference

12 December 2020

Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group

1 reference

12 December 2020

Beta-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes

1 reference

12 December 2020

Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes

1 reference

12 December 2020

Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A.

1 reference

12 December 2020

Apoptosis in cardiac diseases: stress- and mitogen-activated signaling pathways

1 reference

12 December 2020

Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat

1 reference

12 December 2020

Transgenic mice with cardiac overexpression of alpha1B-adrenergic receptors. In vivo alpha1-adrenergic receptor-mediated regulation of beta-adrenergic signaling

1 reference

12 December 2020

Transgenic Galphaq overexpression induces cardiac contractile failure in mice

1 reference

12 December 2020

Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats.

1 reference

12 December 2020

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

1 reference

12 December 2020

Multiple domains of MCIP1 contribute to inhibition of calcineurin activity

1 reference

12 December 2020

Endothelin-1 as a protective factor against beta-adrenergic agonist-induced apoptosis in cardiac myocytes

1 reference

12 December 2020

Rapamycin as rescue therapy in a patient supported by biventricular assist device to heart transplantation with consecutive ongoing rejection.

1 reference

12 December 2020

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

1 reference

12 December 2020

alpha- and beta-adrenergic pathways differentially regulate cell type-specific apoptosis in rat cardiac myocytes

1 reference

12 December 2020

Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group

1 reference

12 December 2020

Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure

1 reference

12 December 2020

Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS alpha overexpression

1 reference

12 December 2020

Cross-talk between the ERK and p70 S6 kinase (S6K) signaling pathways. MEK-dependent activation of S6K2 in cardiomyocytes

1 reference

12 December 2020

Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway

1 reference

12 December 2020

Adrenergic regulation of cardiac myocyte apoptosis

1 reference

12 December 2020

Calcineurin pathway is required for endothelin-1-mediated protection against oxidant stress-induced apoptosis in cardiac myocytes

1 reference

12 December 2020

Signaling pathways for cardiac hypertrophy and failure

1 reference

12 December 2020

Cloning and expression of a cDNA encoding an endothelin receptor

1 reference

12 December 2020

Suppression or induction of apoptosis by opposing pathways downstream from calcium-activated calcineurin

1 reference

12 December 2020

Alpha1-adrenergic receptor subtype mRNAs are differentially regulated by alpha1-adrenergic and other hypertrophic stimuli in cardiac myocytes in culture and in vivo. Repression of alpha1B and alpha1D but induction of alpha1C.

1 reference

12 December 2020

Regulation of the calmodulin-stimulated protein phosphatase, calcineurin

1 reference

12 December 2020

Subtype specific roles of beta-adrenergic receptors in apoptosis of adult rat ventricular myocytes

1 reference

12 December 2020

Apoptosis in the failing human heart

1 reference

12 December 2020

Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor

1 reference

12 December 2020

Phosphorylation and activation of p70s6k by PDK1

1 reference

12 December 2020

Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress

1 reference

12 December 2020

Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice.

1 reference

12 December 2020

Overexpression of alpha1B-adrenergic receptor induces left ventricular dysfunction in the absence of hypertrophy

1 reference

12 December 2020

Programmed cell death in animal development

1 reference

12 December 2020

Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death

1 reference

12 December 2020

Losing heart: the role of apoptosis in heart disease--a novel therapeutic target?

1 reference

12 December 2020

Neurohormonal regulation of myocardial cell apoptosis during the development of heart failure

1 reference

12 December 2020

Apoptosis in myocytes in end-stage heart failure

1 reference

12 December 2020

Endothelin in human congestive heart failure

1 reference

12 December 2020

Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.

1 reference

12 December 2020

10.1023/B:MCBI.0000021368.80389.B9

Identifiers

DOI

1 reference

Dimensions Publication ID

10 August 2017

1011451667

0 references

1 reference